SSG
RMD icon

Summit Securities Group’s ResMed RMD Stock Holding History

Summit Securities Group’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.63K Buy
34
+10
+42% +$2.07K ﹤0.01% 922
2026
Q1 		$5.39K Sell
24
-192
-89% -$47.8K ﹤0.01% 782
2025
Q4 		$52K Sell
216
-35
-14% -$8.95K 0.01% 605
2025
Q3 		$68.7K Buy
251
+153
+156% +$41.8K 0.01% 482
2025
Q2 		$25.3K Buy
+98
New +$23.4K ﹤0.01% 670
2024
Q3 		– Sell
-942
Closed -$180K – 821
2024
Q2 		$180K Buy
+942
New +$191K 0.03% 173
2024
Q1 		– Sell
-1
Closed – – 823
2023
Q4 		$0 Buy
+1
New +$154 ﹤0.01% 866
2023
Q3 		– Sell
-193
Closed -$42K – 953
2023
Q2 		$42K Sell
193
-98
-34% -$21.8K 0.01% 449
2023
Q1 		$64K Sell
291
-1,301
-82% -$282K 0.01% 377
2022
Q4 		$331K Buy
+1,592
New +$350K 0.01% 328
2022
Q3 		– Sell
-303
Closed -$64K – 1134
2022
Q2 		$64K Buy
303
+243
+405% +$51.7K 0.01% 496
2022
Q1 		$15K Buy
+60
New +$14.5K ﹤0.01% 765

Other funds holding RMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Summit Securities Group's RMD Position: Q2 2026 in Review

Summit Securities Group increased its ResMed (RMD) stake by 42% in Q2 2026, buying an estimated $2.07K and bringing the position to 34 shares worth $6.63K. The position accounts for ﹤0.01% of the portfolio, ranked #922.

Summit Securities Group first reported a position in RMD in Q1 2022 and has held it in 12 quarters since. The position peaked at $331K in Q4 2022. 887 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Summit Securities Group held 34 shares of ResMed worth $6.63K as of Q2 2026.
  • Summit Securities Group bought 10 ResMed shares in Q2 2026, an estimated $2.07K.
  • ResMed made up ﹤0.01% of Summit Securities Group's portfolio in Q2 2026, its #922 holding.
  • Summit Securities Group first reported a position in ResMed in Q1 2022 and has held it in 12 quarters since.
  • Summit Securities Group's ResMed position peaked at $331K in Q4 2022.
  • 887 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Summit Securities Group's 13F filing for Q2 2026, filed 3 Aug 2026.